The antiviral medicine remdesivir has been given full approval in the US after a trial showed it cut recovery time by five days
The US Food and Drug Administration (FDA) has approved the first drug to treat Covid-19: remdesivir, an antiviral medicine given through an IV for patients needing hospitalization.
The drug, which California-based Gilead Sciences Inc is calling Veklury, cut the time to recovery from 15 days to 10 on average in a large study led by the US National Institutes of Health.
